SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY ARTICLE M impact

Novo Nordisk to use Anthropic’s Claude for drug research

Novo Nordisk said it will partner with Anthropic to use its science-specific AI platform, Claude, for drug research.

NOVOB

By Alex Janin and Adrià CalatayudNovo Nordisk, the Danish drugmaker behind blockbuster diabetes and weight-loss drugs Ozempic and Wegovy, is partnering with Anthropic to use artificial intelligence for drug research.Novo said Wednesday it would use Anthropic's science-specific platform, known as Cl…

Related stories